Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · IEX Real-Time Price · USD
3.050
+0.230 (8.16%)
At close: Apr 25, 2024, 4:00 PM
3.080
+0.030 (0.98%)
After-hours: Apr 25, 2024, 5:24 PM EDT

Protara Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
0000000002.95
Upgrade
Gross Profit
0000000002.95
Upgrade
Selling, General & Admin
18.6220.7426.422.463.959.528.689.848.494.1
Upgrade
Research & Development
24.9916.8121.0911.983.8811.8521.6918.8712.386.43
Upgrade
Other Operating Expenses
029.5200000000
Upgrade
Operating Expenses
43.6167.0647.4934.447.8321.3730.3628.7120.8710.53
Upgrade
Operating Income
-43.61-67.06-47.49-34.44-7.83-21.37-30.36-28.71-20.87-7.58
Upgrade
Interest Expense / Income
0000.03000000.86
Upgrade
Other Expense / Income
-3.19-1.11-0.24-0.5--0.64-0.4-0.180.51-5.1
Upgrade
Pretax Income
-40.42-65.95-47.25-33.98-7.83-20.73-29.96-28.53-21.38-3.34
Upgrade
Net Income
-40.42-65.95-47.25-33.98-7.83-20.73-29.96-28.53-21.38-3.34
Upgrade
Preferred Dividends
0000006.75006.35
Upgrade
Net Income Common
-40.42-65.95-47.25-33.98-7.83-20.73-36.71-28.53-21.38-9.7
Upgrade
Shares Outstanding (Basic)
1111117300000
Upgrade
Shares Outstanding (Diluted)
1111117300000
Upgrade
Shares Change
0.64%0.24%55.28%180.66%469.54%4.79%4.30%0.59%437.25%1202.94%
Upgrade
EPS (Basic)
-3.57-5.86-4.21-4.70-3.04-45.80-85.20-68.80-52.00-126.40
Upgrade
EPS (Diluted)
-3.57-5.86-4.21-4.70-3.04-45.80-85.20-68.80-52.00-126.40
Upgrade
Free Cash Flow
-37.6-26.58-35.1-24.29-5.49-23.35-22.39-23.96-17.76-10.04
Upgrade
Free Cash Flow Per Share
-3.32-2.36-3.13-3.36-2.13-51.60-51.84-57.86-43.16-131.06
Upgrade
Gross Margin
---------100.00%
Upgrade
Operating Margin
----------257.12%
Upgrade
Profit Margin
----------328.87%
Upgrade
Free Cash Flow Margin
----------340.60%
Upgrade
EBITDA
-40.08-65.7-47.14-33.84-7.81-20.61-29.82-28.4-21.32-2.46
Upgrade
EBITDA Margin
----------83.28%
Upgrade
Depreciation & Amortization
0.340.250.120.10.020.120.150.120.060.03
Upgrade
EBIT
-40.42-65.95-47.25-33.94-7.83-20.73-29.96-28.53-21.38-2.49
Upgrade
EBIT Margin
----------84.29%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).